GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 723 filers reported holding GLAXOSMITHKLINE PLC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $48,000 | -12.7% | 1,350 | 0.0% | 0.07% | +4.6% |
| Q3 2017 | $55,000 | -87.7% | 1,350 | -87.0% | 0.06% | -80.9% |
| Q2 2017 | $446,000 | -64.2% | 10,350 | -65.0% | 0.34% | -56.6% |
| Q1 2017 | $1,247,000 | +9.5% | 29,567 | 0.0% | 0.79% | +14.1% |
| Q4 2016 | $1,139,000 | -26.8% | 29,567 | -18.0% | 0.69% | -21.0% |
| Q3 2016 | $1,556,000 | +9.3% | 36,067 | +9.8% | 0.87% | +3.1% |
| Q2 2016 | $1,424,000 | +8.8% | 32,859 | +1.8% | 0.85% | +21.2% |
| Q1 2016 | $1,309,000 | -8.2% | 32,278 | -8.6% | 0.70% | -5.5% |
| Q4 2015 | $1,426,000 | -2.1% | 35,329 | -6.7% | 0.74% | +3.1% |
| Q3 2015 | $1,456,000 | -11.0% | 37,879 | -3.6% | 0.72% | -8.1% |
| Q2 2015 | $1,636,000 | -9.8% | 39,290 | 0.0% | 0.78% | -11.0% |
| Q1 2015 | $1,813,000 | +8.0% | 39,290 | 0.0% | 0.88% | +11.3% |
| Q4 2014 | $1,679,000 | -12.0% | 39,290 | -5.3% | 0.79% | -9.3% |
| Q3 2014 | $1,907,000 | – | 41,480 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |